Eton Pharmaceuticals (ETON) FCF Margin (2019 - 2025)
Eton Pharmaceuticals (ETON) reported FCF Margin of 54.51% for Q4 2025, down 4784.0% on a YoY basis from 1.16% in Q4 2024, and down 204.26% sequentially from 52.28% in Q3 2025.
Eton Pharmaceuticals (ETON) FCF Margin (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 7 years of FCF Margin data on file, last reported at 54.51% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin fell 4784.0% year-over-year to 54.51%; the trailing twelve-month figure through Dec 2025 stood at 12.75% (up 1033.0% YoY), and the FY2025 full-year result was 12.75%, up 1033.0% from the prior year.
- FCF Margin declined to 54.51% in Q4 2025, from 52.28% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 59.21% in Q2 2023 to a low of 380.9% in Q3 2021.
- A 5-year average of 12.09% and a median of 12.26% in 2023 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 1425297 bps in 2021, while the deepest fall reached 24095071 bps in 2021.
- Tracing ETON's FCF Margin over 5 years: stood at 84.05% in 2021, then surged by 140 bps to 33.28% in 2022, then tumbled by 96 bps to 1.3% in 2023, then slumped by 614 bps to 6.67% in 2024, then tumbled by 717 bps to 54.51% in 2025.
- Business Quant data shows ETON's FCF Margin at 54.51% in Q4 2025, 52.28% in Q3 2025, and 42.05% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | -54.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -54.51% |
| Sep 30, 2025 | 52.28% |
| Jun 30, 2025 | 42.05% |
| Mar 31, 2025 | 12.09% |
| Dec 31, 2024 | -6.67% |
| Sep 30, 2024 | 28.59% |
| Jun 30, 2024 | 13.83% |
| Mar 31, 2024 | -31.22% |
| Dec 31, 2023 | 1.30% |
| Sep 30, 2023 | 12.42% |
| Jun 30, 2023 | 59.21% |
| Mar 31, 2023 | -29.19% |
| Dec 31, 2022 | 33.28% |
| Sep 30, 2022 | -34.06% |
| Jun 30, 2022 | 49.00% |
| Mar 31, 2022 | 55.51% |
| Dec 31, 2021 | -84.05% |
| Sep 30, 2021 | -380.90% |
| Jun 30, 2021 | -12.03% |
| Mar 31, 2021 | 31.23% |